Alexander M. Reznik

Reznik A.M., Karpenko O.A., Shumakova E.A., Mudrak A.V., Sokolov A.V., Nazimova S.V., Sayfulina A.M., Eliseenko A.M., Matvievskaya T.K., Khannanova A.N., Revenko V.I., Shcherbakov D.V., Martynyuk Y.L., Arbuzov A.L., Yatsenko O.A., Alekseeva P.N., Berdalin A.B., Burygina L.A.

Dynamics of Clinical Manifestations and Social Functioning in Schizophrenia: A Non-interventional Observational Study of Paliperidone Palmitat Dosage Forms

Consortium Psychiatricum (2024. Vol. 5, no. 4, pp. 16–38)

DOI

10.17816/CP15567

12

Telesheva K.Y., Савенкова V.I., Morozova I.O., Ochneva A.G., Zeltser A.I., Andreyuk D.S., Reznik A.M., Mukhin V.N., Melkonian G.G., Lytkina K.A., Mitrofanov A.A., Morozova A.Yu.

Potential Neurophysiological Markers of Combat-Related Post-Traumatic Stress Disorder: A Cross-Sectional Diagnostic Study

Consortium Psychiatricum (2024. Vol. 5, no. 2, pp. 31–44)

DOI

10.17816/CP15512

28

Reznik A.M., Arbuzov A.L., Murin S.P.

Negative Symptoms of Schizophrenia: New Prospects of Cariprazine Treatment

Consortium Psychiatricum (2020. Vol. 1, no. 2, pp. 43–51)

24

Anna, Stekolshchikova E.A., Morozova A.Yu., Anikanov N., Alekseeva P.N., Khobta E.B., Andreyuk D.S., Zozulya S.A., Barkhatova A.N., Klyushnik T.P., Reznik A.M., Kostyuk G.P., Khaitovich P.

Ceramides: Shared Lipid Biomarkers of Cardiovascular Disease and Schizophrenia

Consortium Psychiatricum (2021. Vol. 2, no. 3, pp. 35–43)

DOI

10.17816/CP101

28

Reznik A.M., Syunyakov T.S., Arbuzov A.L.

Alcohol Addiction in War Veterans Treated in a In-patient Psychiatric Facility: Incidence, Comorbidity with PTSD Symptoms, Association with Combat Stressors

Consortium Psychiatricum (2022. Vol. 3, no. 3, pp. 73–89)

DOI

10.17816/CP188

50

Reznik A.M., Syunyakov T.S., Akhmerova I.Yu., Butylin D.Yu., Vasilenko A.O., Gvozdetckii A.N., Gizatullin T.R., Gilmanshina G.V., Golosov E.A., Kolchev S.A., Linova L.P., Miron D.V., Mudrak A.V., Oleichik I., Sizov S.V., Tarakanova E.A., Chesnokova O.I.

Clinical Effectiveness of Lurasidone Monotherapy in Patients with Acute Episodes of Schizophrenia and Associated Symptoms of Depression

Consortium Psychiatricum (2022. Vol. 3, no. 3, pp. 58–72)

DOI

10.17816/CP172

101

Reznik A.M., Syunyakov T.S., Mudrak A.V., Zakharov N.B., Popova Zh.B., Khoroshilova A.N., Khurbatova I.G., Sayfulina A.M., Eliseenko A.M., Matvievskaya T.K., Khannanova A.N.

Treatment of Depression with Vortioxetine and Second Generation Antipsychotics During the Period of Remission Formation in Schizophrenia (Interim Data Analysis)

Consortium Psychiatricum (2023. Vol. 4, no. 1, pp. 18–36)

DOI

10.17816/CP3728

29